- Phase II study of Disulfiram and Cisplatin in Refractory Germ Cell Tu…
Number of the records: 1  

Phase II study of Disulfiram and Cisplatin in Refractory Germ Cell Tumors. The GCT-SK-006 phase II trial

  1. Phase II study of Disulfiram and Cisplatin in Refractory Germ Cell Tumors. The GCT-SK-006 phase II trial. In Onkológia. ISSN 1336-8176. Bratislava : SOLEN, 2022, 2022, roč. 17, č. 4, s. 298.
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.

Accept allSettingsReject all